Logo image of CCLDO

CARECLOUD INC - CCLD 8 3/4 PERP (CCLDO) Stock Fundamental Analysis

NASDAQ:CCLDO - Nasdaq - US14167R3084 - Currency: USD

20.1  -0.15 (-0.76%)

After market: 19.28 -0.82 (-4.08%)

Fundamental Rating

5

CCLDO gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 37 industry peers in the Health Care Technology industry. CCLDO is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. CCLDO has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

CCLDO had negative earnings in the past year.
In the past year CCLDO had a positive cash flow from operations.
In the past 5 years CCLDO always reported negative net income.
Of the past 5 years CCLDO 4 years had a positive operating cash flow.
CCLDO Yearly Net Income VS EBIT VS OCF VS FCFCCLDO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M -60M

1.2 Ratios

CCLDO has a Return On Assets of -5.12%. This is in the better half of the industry: CCLDO outperforms 75.68% of its industry peers.
Looking at the Return On Equity, with a value of -6.96%, CCLDO is in the better half of the industry, outperforming 75.68% of the companies in the same industry.
CCLDO has a better Return On Invested Capital (15.91%) than 94.59% of its industry peers.
Industry RankSector Rank
ROA -5.12%
ROE -6.96%
ROIC 15.91%
ROA(3y)-32.11%
ROA(5y)-24.15%
ROE(3y)-57.71%
ROE(5y)-41.4%
ROIC(3y)N/A
ROIC(5y)N/A
CCLDO Yearly ROA, ROE, ROICCCLDO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

The Operating Margin of CCLDO (10.13%) is better than 86.49% of its industry peers.
CCLDO's Operating Margin has improved in the last couple of years.
CCLDO has a worse Gross Margin (45.67%) than 64.86% of its industry peers.
In the last couple of years the Gross Margin of CCLDO has grown nicely.
Industry RankSector Rank
OM 10.13%
PM (TTM) N/A
GM 45.67%
OM growth 3Y59.79%
OM growth 5Y95.05%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.11%
GM growth 5Y4.51%
CCLDO Yearly Profit, Operating, Gross MarginsCCLDO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

More info and screens

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CCLDO is creating some value.
The number of shares outstanding for CCLDO has been increased compared to 1 year ago.
The number of shares outstanding for CCLDO has been increased compared to 5 years ago.
CCLDO has a better debt/assets ratio than last year.
CCLDO Yearly Shares OutstandingCCLDO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
CCLDO Yearly Total Debt VS Total AssetsCCLDO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

2.2 Solvency

CCLDO has an Altman-Z score of 27.54. This indicates that CCLDO is financially healthy and has little risk of bankruptcy at the moment.
CCLDO has a better Altman-Z score (27.54) than 91.89% of its industry peers.
The Debt to FCF ratio of CCLDO is 0.01, which is an excellent value as it means it would take CCLDO, only 0.01 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 0.01, CCLDO belongs to the best of the industry, outperforming 86.49% of the companies in the same industry.
CCLDO has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of CCLDO (0.00) is better than 67.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Altman-Z 27.54
ROIC/WACC1.47
WACC10.83%
CCLDO Yearly LT Debt VS Equity VS FCFCCLDO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

CCLDO has a Current Ratio of 1.69. This is a normal value and indicates that CCLDO is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of CCLDO (1.69) is comparable to the rest of the industry.
A Quick Ratio of 1.65 indicates that CCLDO should not have too much problems paying its short term obligations.
CCLDO has a Quick ratio (1.65) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.69
Quick Ratio 1.65
CCLDO Yearly Current Assets VS Current LiabilitesCCLDO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

4

3. Growth

3.1 Past

CCLDO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 81.03%, which is quite impressive.
The Revenue has decreased by -0.45% in the past year.
CCLDO shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.47% yearly.
EPS 1Y (TTM)81.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)-0.45%
Revenue growth 3Y-7.4%
Revenue growth 5Y11.47%
Sales Q2Q%6.43%

3.2 Future

CCLDO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 67.81% yearly.
CCLDO is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.18% yearly.
EPS Next Y151%
EPS Next 2Y67.81%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year0.95%
Revenue Next 2Y4.18%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CCLDO Yearly Revenue VS EstimatesCCLDO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2030 100M 200M 300M
CCLDO Yearly EPS VS EstimatesCCLDO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -0.5 -1 -1.5

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CCLDO. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 123.16, CCLDO can be considered very expensive at the moment.
CCLDO's Price/Forward Earnings is on the same level as the industry average.
CCLDO's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.15.
Industry RankSector Rank
PE N/A
Fwd PE 123.16
CCLDO Price Earnings VS Forward Price EarningsCCLDO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 100

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CCLDO is valued a bit cheaper than the industry average as 72.97% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, CCLDO is valued a bit cheaper than the industry average as 64.86% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 57.94
EV/EBITDA 33.68
CCLDO Per share dataCCLDO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CCLDO's earnings are expected to grow with 67.81% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y67.81%
EPS Next 3YN/A

More info and screens

6

5. Dividend

5.1 Amount

CCLDO has a Yearly Dividend Yield of 5.53%, which is a nice return.
Compared to an average industry Dividend Yield of 37.28, CCLDO pays a better dividend. On top of this CCLDO pays more dividend than 94.59% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.40, CCLDO pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.53%

5.2 History

On average, the dividend of CCLDO grows each year by 21.20%, which is quite nice.
CCLDO has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)21.2%
Div Incr Years1
Div Non Decr Years1
CCLDO Yearly Dividends per shareCCLDO Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

The dividend of CCLDO is growing, but earnings are growing more, so the dividend growth is sustainable.
DPN/A
EPS Next 2Y67.81%
EPS Next 3YN/A
CCLDO Yearly Income VS Free CF VS DividendCCLDO Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M

More info and screens

CARECLOUD INC - CCLD 8 3/4 PERP

NASDAQ:CCLDO (5/30/2025, 8:00:02 PM)

After market: 19.28 -0.82 (-4.08%)

20.1

-0.15 (-0.76%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)05-06 2025-05-06/bmo
Earnings (Next)08-11 2025-08-11/bmo
Inst Owners11.24%
Inst Owner ChangeN/A
Ins Owners37.42%
Ins Owner ChangeN/A
Market Cap850.63M
Analysts82
Price Target44.75 (122.64%)
Short Float %0%
Short Ratio0.15
Dividend
Industry RankSector Rank
Dividend Yield 5.53%
Yearly Dividend0.92
Dividend Growth(5Y)21.2%
DPN/A
Div Incr Years1
Div Non Decr Years1
Ex-Date06-30 2025-06-30 (0.18229)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)60.78%
Min EPS beat(2)21.57%
Max EPS beat(2)100%
EPS beat(4)3
Avg EPS beat(4)-41.12%
Min EPS beat(4)-357.52%
Max EPS beat(4)100%
EPS beat(8)4
Avg EPS beat(8)-16.18%
EPS beat(12)8
Avg EPS beat(12)-4.32%
EPS beat(16)12
Avg EPS beat(16)5.81%
Revenue beat(2)1
Avg Revenue beat(2)2.25%
Min Revenue beat(2)-1.1%
Max Revenue beat(2)5.6%
Revenue beat(4)1
Avg Revenue beat(4)0.16%
Min Revenue beat(4)-1.99%
Max Revenue beat(4)5.6%
Revenue beat(8)1
Avg Revenue beat(8)-3.14%
Revenue beat(12)1
Avg Revenue beat(12)-3.28%
Revenue beat(16)4
Avg Revenue beat(16)-1.86%
PT rev (1m)-24.17%
PT rev (3m)32.49%
EPS NQ rev (1m)-60%
EPS NQ rev (3m)142.1%
EPS NY rev (1m)-11.76%
EPS NY rev (3m)148.54%
Revenue NQ rev (1m)-4.88%
Revenue NQ rev (3m)-3.71%
Revenue NY rev (1m)-0.43%
Revenue NY rev (3m)-0.52%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 123.16
P/S 7.56
P/FCF 57.94
P/OCF 39.22
P/B 15.7
P/tB 46.96
EV/EBITDA 33.68
EPS(TTM)-0.22
EYN/A
EPS(NY)0.16
Fwd EY0.81%
FCF(TTM)0.35
FCFY1.73%
OCF(TTM)0.51
OCFY2.55%
SpS2.66
BVpS1.28
TBVpS0.43
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.12%
ROE -6.96%
ROCE 20.14%
ROIC 15.91%
ROICexc 18.08%
ROICexgc 65.54%
OM 10.13%
PM (TTM) N/A
GM 45.67%
FCFM 13.05%
ROA(3y)-32.11%
ROA(5y)-24.15%
ROE(3y)-57.71%
ROE(5y)-41.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y52.71%
ROICexcg growth 5Y104.32%
ROICexc growth 3Y91.65%
ROICexc growth 5Y92.03%
OM growth 3Y59.79%
OM growth 5Y95.05%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.11%
GM growth 5Y4.51%
F-Score7
Asset Turnover1.53
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Debt/EBITDA 0
Cap/Depr 50.58%
Cap/Sales 6.23%
Interest Coverage 28.5
Cash Conversion 85.88%
Profit Quality N/A
Current Ratio 1.69
Quick Ratio 1.65
Altman-Z 27.54
F-Score7
WACC10.83%
ROIC/WACC1.47
Cap/Depr(3y)74.91%
Cap/Depr(5y)76.9%
Cap/Sales(3y)8.36%
Cap/Sales(5y)8%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)81.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
EPS Next Y151%
EPS Next 2Y67.81%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.45%
Revenue growth 3Y-7.4%
Revenue growth 5Y11.47%
Sales Q2Q%6.43%
Revenue Next Year0.95%
Revenue Next 2Y4.18%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y416.02%
EBIT growth 3Y47.96%
EBIT growth 5Y117.42%
EBIT Next Year208.61%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y107.65%
FCF growth 3Y68.43%
FCF growth 5Y21.21%
OCF growth 1Y13.67%
OCF growth 3Y15.69%
OCF growth 5Y22.06%